These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22739150)

  • 1. [Expression of two subtype molecules of CD133 in childhood with B linage acute lymphoblastic leukemia and its clinical significance].
    Zhao WL; Nie SS; Xu YY; Zhang YL; Guo DD; Pan J; Wang JM; Zhang XG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):536-40. PubMed ID: 22739150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CD133 in bone marrow cells of patients with leukemia and myelodysplastic syndrome].
    Wang W; Wang HY; Zhao HX; Cui ZG; Li GL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):470-3. PubMed ID: 17605847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of CD133 in acute leukemia and its clinical significance].
    Zhou Y; Meng HX; Yu Z; Li Q; Wang YF; Mai YJ; Han JL; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):401-4. PubMed ID: 15355691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AC133 expression in egyptian children with acute leukemia: impact on treatment response and disease outcome.
    Elgendi HM; Mekawy MA; Abdel Wahab SE; Tawfik LM; Ismail EA; Adly AA
    J Pediatr Hematol Oncol; 2010 May; 32(4):286-93. PubMed ID: 20224439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of CD34(+)CD38(+) and CD34(+)CD38(low/-) subgroups in bone marrow of patients with B lymphoblastic leukemia].
    Hao L; Liu YR; Wang YZ; Chang Y; Qin YZ; Li JL; Li LD; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):801-5. PubMed ID: 22931632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of dynamic monitoring the minimal residual disease in childhood B-lineage acute lymphoblastic leukemia by multiparameter flow cytometry].
    Guo DD; Zhao WL; Zhang YL; Pang L; Che L; He HL; Chai YH; Ji ZH; Ji XQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1346-51. PubMed ID: 23257430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance].
    Zhong LY; DU X; Geng SX; Weng JY; Zheng HT; Wu SJ; Li YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):854-5. PubMed ID: 21602141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of sequential monitoring minimal residual disease in childhood B-cell acute lymphoblastic leukemia].
    Wang L; Jiang H; Li H; Shao JB; Lu ZH; Yang JW; Yang WQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):400-3. PubMed ID: 21781499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of detecting minimal residual disease in acute childhood B-cell lymphoblastic leukemia with flow cytometry].
    Zhang LP; Cheng YF; Liu GL; Lu AD; Liu YR; Wang H
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):481-5. PubMed ID: 16083543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of effective antigen combinations in childhood B lineage acute lymphoblastic leukemia].
    Liu Y; Tang JY; Xu C; Gu LJ; Xue HL; Chen J; Pan C; Dong L; Zhou M
    Zhonghua Er Ke Za Zhi; 2009 May; 47(5):366-70. PubMed ID: 19573409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of minimal residual disease in childhood B-cell acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Chen J; Jiang LM; Dong L; Pan C; Ye H; Song DL; Xue HL; Tang JY; Wang YP; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):120-3. PubMed ID: 16732969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression and clinical significance of early differentiation antigens in acute leukemia].
    Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD133 in acute leukemia.
    Tolba FM; Foda ME; Kamal HM; Elshabrawy DA
    Med Oncol; 2013 Jun; 30(2):527. PubMed ID: 23532815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.